We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

COMIRNATY (tozinameran) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection vial (377111)

ARTG ID 377111

ARTG Name

COMIRNATY (tozinameran) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection vial

Product name

COMIRNATY (tozinameran) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection vial

ARTG Date

6 December 2021

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

tozinameran

Licence category

RE

Licence status

A

Summary

Product information

Consumer medicine information

Related information

COMIRNATY (Tozinameran [mRNA]) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection vial, Pfizer Australia Pty Ltd, CON-887

6 December 2021

Section 14 consent

Consent to Supply while noncompliant with standards. The consent is effective from 6 December 2021 until 3 December 2023.
COMIRNATY (tozinameran) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection vial, Pfizer Australia Pty Ltd, CON-1096

19 April 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 19 April 2023 until 3 December 2023.